Nomogram based on high-density lipoprotein cholesterol for the occurrence of preoperative deep vein thrombosis in patients with intertrochanteric femur fracture: a retrospective study

Intertrochanteric femur fractures (IFF) have been more common in recent years [1]. With a 30-day mortality rate ranging from 1.0 to 6.5% and a one-year mortality rate considerably rising to 37.3%, IFF is the primary cause of death in the older population [2]. With its benefits of ease of use, affordability, and speed of examination, X-ray imaging is crucial in the diagnosis of IFF [3]. Patients with IFF need to stay in the hospital for an extended period of time, and they cannot return to their pre-fracture activities, joint function, or independent quality of life once they are discharged [4]. Patients with IFF have a much better prognosis after surgery [5], with two typical surgical techniques being intramedullary fixation using a proximal femoral nail system and extramedullary fixation using a plate system [6‐8]. As the population ages, IFF is frequently associated with a number of serious side effects, such as deep vein thrombosis, nonunion of the fracture, and femoral head necrosis, which in extreme circumstances can be fatal [9]. Autonomy and physical function can be markedly enhanced by perioperative therapies [10].

Patients who have suffered lower limb fractures are frequently affected by deep vein thrombosis (DVT), which is linked to decreased blood flow velocity, decreased limb activity, and post-fracture limb oedema [11]. DVT incidence rates in trauma fracture patients range from 13.5 to 33.7%, according to published research [12]. Vascular colour Doppler ultrasonography is the main tool used to diagnose DVT, yet early on, patients with intertrochanteric fractures may find it difficult to cooperate [13, 14]. Pulmonary embolism is one potentially fatal outcome of DVT [15]. Early pharmacological and mechanical prophylaxis for DVT has been recommended by prior research; nevertheless, pharmacological prophylaxis has a risk of increased bleeding and brain haemorrhage because it impairs coagulation function [16]. For patients to receive the most benefit, early and precise prediction of DVT incidence is therefore essential, as it can substantially assist doctors in making early decisions [17].

The nomogram, one of the new prediction models, is a useful tool to help physicians because of its ease of use and friendliness. Nomograms are being created and validated by an increasing number of academics [18]. The necessity of creating a nomogram for DVT has been highlighted by the clinical consensus on early preventative intervention for DVT [19]. Jiabao Jiang and colleagues [20] used blood indicators to create a nomogram model for preoperative venous thrombosis in the calf muscles of older patients who had hip fractures. Using coagulation markers, Dongcheng Xu et al. [21] created a nomogram model for postoperative DVT in patients suffering from spinal infections.

This research attempts to gather routine blood and biochemical examination findings at the time of patient admission by means of a retrospective analysis conducted in two centres. The objective is to build a predictive model that will allow for early preventive intervention in patients with intertrochanteric femur fractures in the event of deep vein thrombosis.

Five hundred and thirty-four individuals with intertrochanteric femur fractures were gathered for this investigation from two sizable medical facilities. Figure 1 illustrates that 338 individuals in all were included in the retrospective analysis, but 196 patients were excluded for a variety of reasons. There were 200 patients in the training group and 138 patients in the validation group. To confirm that there was no selection bias in this investigation, we used intergroup comparison to show that there was no statistically significant difference in baseline data between the patient groups that were included and those that were excluded (Table 1).

The two groups' baseline data were compared. With a median age of 79.5 years (66, 86), there were 92 female patients (46%), making up the training group. 110 patients (or 55%) had fractures to their left intertrochanteric femur. There were 94 (47%), 78 (39%), 89 (44.5%), and 39 (19.5%) cases of hypertension, diabetes, smoking history, and alcohol use history, respectively. The comparability of the data was demonstrated by the lack of statistically significant variations (p > 0.05) in the baseline data between the two groups (Table 1).

Based on whether DVT was present or not, the data from the two groups were merged and split into the DVT group and the No DVT group. Table 2 displays significantly significant differences (p < 0.05) in LYM, HDL-C, ALB, AST, ALT, and Cr between the two groups. An ROC curve was created using the parameters that had substantial differences, and the area under the curve (AUC) was computed (Fig. 2).

Univariate logistic regression analysis was performed with clinical factors included. The results indicated that the following factors were predictive of DVT: HDL-C (0.22 [0.11–0.43], p < 0.001), LYM (0.05 [0.02, 0.13], p < 0.001), ALB (0.19 [0.1, 0.13], p < 0.001), AST (0.32 [0.16, 0.63], p = 0.001), ALT (0.47 [0.25–0.9], p = 0.023), Cr (0.33 [0.17–0.64], p = 0.001), and Cl (2.53 [1.14–5.62], p = 0.023) (Table 3). The multivariate logistic regression analysis incorporated the significant factors found in the univariate study (p < 0.1). Table 3 displays the data, which indicate that ALB (0.83[0.74, 0.94], p = 0.002), LYM (0.02 [0.01–0.09], p < 0.001), and HDL-C (0.18[0.04, 0.71], p = 0.014) are independent predictors.

Using R Studio software, we created a nomogram model based on multifactor analysis to further test the prediction power of several factors on patients with IFF. We created a nomogram (Fig. 3) using the training group data. Plotting the training group's ROC curve (Fig. 4A), which shows an excellent predictive ability with a C-index of 0.907, verified the nomogram's predictive performance. The training group's calibration curve (Fig. 5A) revealed an average inaccuracy of 0.022. In the threshold range of 0.01–0.95, the training group's decision curve analysis (DCA) (Fig. 6A) showed good clinical benefit.

The data from the validation group were used for validation at the same time. The nomogram's (Fig. 4B) ROC curve showed a C-index of 0.877. An average inaccuracy of 0.012 was displayed by the calibration curve (Fig. 5B). Good clinical effect was shown by the DCA (Fig. 6B) within the threshold range of 0.01–0.85.

To sum up, the nomogram performed well in terms of prediction with few mistakes in both the training and validation groups, which was advantageous for most clinical patients.

Preoperative deep vein thrombosis (DVT) is more common in female, elderly, long-term hospital patients, smokers, and patients with underlying medical conditions such liver and kidney diseases, as evidenced by the previous meta-analysis of DVT in patients with hip fractures [22, 23]. In order to reduce the influence of confounding factors, we therefore thought about incorporating these components in the study prior to performing a multivariate regression analysis. A nomogram model was created based on the findings, which demonstrated that lymphocytes, albumin, and high-density lipoprotein cholesterol are independent predictors of preoperative DVT in patients with IFF.

The effect of HDL-C on the development of deep vein thrombosis has drawn the attention of numerous academics. The primary way that HDL-C inhibits platelet aggregation is by downregulating the formation of thromboxane A2. It also inhibits platelet activation by producing and releasing bioactive molecules. Furthermore, HDL-C has been shown to support endothelial cell integrity [24, 25]. Through a retrospective analysis, Xu Bin-Bin et al. [26] confirmed the independent connection between low plasma HDL-C levels and the development of DVT in patients who had suffered severe fractures. Patients with deep vein thrombosis had a significantly higher monocyte-to-HDL ratio, according to Doğan et al. [27]. Moreover, researchers have looked into how serum albumin affects the development of deep vein thrombosis. According to Wu Yi-Lun et al. [28], serum albumin can be utilised as a predictor of DVT risk and is linked to preoperative DVT in older individuals with hip fractures. Serum albumin levels may be able to predict venous thromboembolism in rheumatology inpatients, according to Peng et al. [29]. Furthermore, lymphocytes, one type of inflammatory agent, also play a role in the development of deep vein thrombosis. According to research by Hasselwander Solveig et al. [30], mice devoid of B lymphocytes indirectly encourage the development of venous thrombosis. Furthermore, it has been demonstrated that a multitude of inflammatory variables are linked to the development of deep vein thrombosis [31].

Finding out a patient's DVT incidence rate as soon as possible is essential since DVT therapy and prevention have a big clinical impact. As a result, the creation of nomograms for the occurrence of DVT has gained popularity among academics in recent years. Nevertheless, there isn't presently a nomogram that uses LYM, ALB, and HDL-C to forecast the risk of DVT in individuals who have intertrochanteric fractures. Constructed based on the blood test results of patients upon admission, the nomogram in this study offers strong prediction performance and can be clinically beneficial for a large number of patients.

There are several benefits to this study: (1) This work is a retrospective analysis from two Chinese centres, and the model is dependable and simple to use because the nomogram has been verified by an external validation set. In order to achieve early prediction and assist more patients, the study's second goal is to gather pertinent data at the time of admission.

As of right moment, we have two study limitations to recognise. First off, our knowledge of the incidence and management of DVT is limited since we were unable to follow up with patients for long-term and postoperative DVT occurrence. This is primarily because most patients receive prophylactic anticoagulant medication following surgery, which surely affects the outcome significantly. Second, we want to increase the quantity of data and centres in the future. Even though we have already conducted our study in two centres and found no statistically significant differences in the baseline data between the excluded and included groups, we still wish to further validate our findings by extending our study to more centres in order to benefit a greater number of patients.

In order to achieve the goal of early prevention and treatment and benefit more patients, clinical practitioners can evaluate the risk of DVT incidence in the early stages with the assistance of the nomogram built based on HDL-C, ALB, and LYM.